Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world effectiveness of golimumab in adult patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis and an inadequate response to initial TNFi therapy in Greece: the GO-BEYOND prospective, observational study.
Athanassiou P, Psaltis D, Georgiadis A, Katsifis G, Theodoridou A, Gazi S, Sidiropoulos P, Tektonidou MG, Bounas A, Kandyli A, Vounotrypidis P, Sakellariou GT, Vassilopoulos D, Huang Z, Petrikkou E, Boumpas D. Athanassiou P, et al. Among authors: georgiadis a. Rheumatol Int. 2023 Oct;43(10):1871-1883. doi: 10.1007/s00296-023-05376-5. Epub 2023 Jul 5. Rheumatol Int. 2023. PMID: 37402886
Clinical course and outcome of early rheumatoid arthritis.
Papadopoulos IA, Katsimbri P, Katsaraki A, Temekonidis T, Georgiadis A, Drosos AA. Papadopoulos IA, et al. Among authors: georgiadis a. Rheumatol Int. 2001 Jul;20(5):205-10. doi: 10.1007/s002960100106. Rheumatol Int. 2001. PMID: 11518041
Outcome of refractory to conventional and/or biologic treatment adult Still's disease following canakinumab treatment: Countrywide data in 50 patients.
Laskari K, Tektonidou MG, Katsiari C, Athanassiou P, Dimopoulou D, Gerodimos C, Salamaliki C, Papagoras C, Settas L, Vassilopoulos D, Voulgari PV, Zakalka M, Georgiadis A, Gkoni G, Daoussis D, Dimitroulas T, Iliou C, Kallitsakis I, Grika EP, Mavragani C, Pikazis D, Raftakis J, Sarikoudis T, Kougkas N, Soukera D, Theodorou E, Tsatsani P, Tsiakou E, Vlachoyiannopoulos P, Vosvotekas G, Sfikakis PP. Laskari K, et al. Among authors: georgiadis a. Semin Arthritis Rheum. 2021 Feb;51(1):137-143. doi: 10.1016/j.semarthrit.2020.10.011. Epub 2020 Dec 19. Semin Arthritis Rheum. 2021. PMID: 33383289
Persistence on subcutaneous tocilizumab as monotherapy or in combination with synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients in Greece (EMBRACE study): a multicenter, post-marketing, non-interventional, observational trial.
Athanassiou P, Katsimbri P, Bounas A, Gazi S, Sarikoudis T, Syrigou V, Boumpas D; EMBRACE Study Group. Athanassiou P, et al. Clin Rheumatol. 2024 May;43(5):1469-1478. doi: 10.1007/s10067-024-06916-5. Epub 2024 Mar 12. Clin Rheumatol. 2024. PMID: 38472527 Free PMC article.
238 results